Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Cytoki Pharma logo — Leveraging lipidated IL-22 to treat metabolic diseases and I...

Cytoki Pharma

Leveraging lipidated IL-22 to treat metabolic diseases and IBD

Founded 2019 Denmark Denmark 5 employees Series A Total: $45.00M Biotechnology, Life Sciences

General Information

Company Name Cytoki Pharma
Founded Year 2019
Location Denmark Denmark +1
Employees 5
Industries Biotechnology, Life Sciences
Funding Stage Series A
Social

Get notified when Cytoki Pharma moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Cytoki Pharma

Cytoki Pharma, founded in 2019, is a pioneering clinical-stage biotechnology company based in Denmark. Specializing in the development of novel medicines, the company is leveraging lipidated IL-22 to target both metabolic diseases and inflammatory bowel disease (IBD). Their innovative approach positions them as a cutting-edge player within the Biotechnology and Life Sciences industries.

In May 2021, Cytoki Pharma secured a significant $45.00M Series A investment, underscoring strong investor confidence. This funding round was led by notable investors including Seventure Partners, ND Capital, Ysios Capital, and Lundbeckfonden Emerge. The financial backing is a strong testament to the market potential and scientific promise of their unique approach to treating prevalent and challenging health conditions.

Taxonomy: clinical stage, metabolic diseases, inflammatory bowel disease (IBD), epithelial injury, immune system modulation, cytokine therapy, IL-22 biology, protein engineering, long-acting proteins, novel medicines, unmet medical needs, drug development, organ injury treatment

Services & Products

Development of IL-22 analogues
Phase 2 clinical evaluation of CK-10045
Creation of therapies for metabolic and epithelial-related diseases

Target Customers

Patients with metabolic diseases Individuals suffering from obesity People with type 2 diabetes Patients with inflammatory bowel disease Healthcare professionals in metabolic and inflammatory diseases

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor Investor
•••• •••• 		04 May 2021

Cytoki Pharma Alternatives & Competitors

Cytoki Pharma vs
AM-Pharma
AM-Pharma The Netherlands

A clinical stage biopharmaceutical company leading in the development of a treatment for acute kidne...

Series Unknown
21 employees
Biopharma, Biotechnology
Cytoki Pharma vs
Kynos Therapeutics
Kynos Therapeutics United Kingdom

Developing first-in-class therapies at the interface of inflammation, metabolism and immunity

Acquired
4 employees
Biotechnology, Health Care
Cytoki Pharma vs
Ela Pharma Ltd.
Ela Pharma Ltd. Israel

Inhibiting Necrosis

2 employees
Biopharma, Biotechnology

FAQ About Cytoki Pharma

Leveraging lipidated IL-22 to treat metabolic diseases and IBD
Cytoki Pharma was founded in 2019.
Cytoki Pharma is headquartered in Denmark.
Cytoki Pharma operates in the following industries: Biotechnology, Life Sciences.
Cytoki Pharma has approximately 5 employees.
Cytoki Pharma has completed 1 funding round, raising a total of $45.00M. The latest funding stage is Series A.
Cytoki Pharma offers: Development of IL-22 analogues, Phase 2 clinical evaluation of CK-10045, Creation of therapies for metabolic and epithelial-related diseases.
Top alternatives and competitors to Cytoki Pharma include AM-Pharma, Kynos Therapeutics, Ela Pharma Ltd., PharmaBizConnect, Telara Pharma. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cytoki Pharma and AM-Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Cytoki Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy